miR-9 and miR-181a in exosomes derived from breast cancer were identified to target SOCS3 and PIAS3, respectively, and further activated the JAK/STAT pathway, thus promoting the amplification and development of eMDSC (41). Here, SOAT1 is linked to breast cancer.